Apollo Hospitals Chennais team for gastrointestinal kirurgi har nået en betydelig milepæl i udviklingen af ​​minimalt invasiv pleje med over 100 robotkirurgiske mave-tarmoperationer og over 50 komplekse procedurer i bugspytkirtlen og leveren, der er udført med succes. Disse resultater afspejler teamets voksende ekspertise inden for håndtering af komplekse mave-tarm- og hepatopankreatobiliære tilstande ved hjælp af avancerede robotassisterede teknikker. Nøgleprocedurer omfatter Whipples kirurgi, højre hepatektomi, højre posterior sektionektomi og Freys procedure – udført med præcision og konsistens. Programmet ledes af Dr. Santhosh Anand, Sr. Consultant – Surgical Gastroenterology & Robotic Surgeon, hvis lederskab har været afgørende for at opbygge og skalere denne kapacitet. Ved at udnytte da Vinci-robotkirurgisystemet er teamet i stand til at operere med forbedret visualisering, præcision og kontrol. Dette resulterer i mindre snit, reduceret kirurgisk traume og hurtigere restitution for patienterne. Med et stærkt fokus på resultater, innovation og patientcentreret pleje fortsætter Apollo Hospitals Chennai med at sætte nye standarder inden for robotkirurgisk mave-tarmkirurgi.

 Apollo Hospitals Chennai har lanceret Indiens første robot- og telekirurgiprogram med etableringen af ​​Apollo Institute of Robotics & Telesurgery (ART), hvilket styrker deres lederskab inden for teknologibaseret kirurgisk innovation. Platformen integrerer robotplatforme med digital tilslutning for at muliggøre fjernkirurgisk vejledning, træning og samarbejde og dermed hjælpe med at udvide specialiseret kirurgisk ekspertise til hospitaler på tværs af geografiske områder. Programmet blev afsløret under det 6. Apollo International Colorectal Symposium (AICRS) 2026, som samlede førende kirurger og forskere for at diskutere nye innovationer inden for minimalt invasiv og robotassisteret kirurgi. Instituttet sigter mod at fremme klinisk ekspertise, kompetenceudvikling og videnudveksling gennem telekirurgibaseret mentorordning og samarbejdsprocedurer. En vigtig milepæl, der blev fremhævet under lanceringen, var den stigende anvendelse af robotbaseret kolorektalkirurgi på Apollo Hospitals Chennai. Dr. Venkatesh Munikrishnan og hans team har gennemført over 1,000 robotbaserede kolorektale procedurer, herunder en af ​​de største personlige serier af robotbaserede endetarmskræftresektioner i regionen. Denne omfattende erfaring har bidraget til at positionere Apollo Hospitals Chennai som et subspecialiseret center for behandling af endetarmskræft og et førende træningscenter for avanceret robotkirurgi med kolorektal kirurgi, der tiltrækker kirurger og fellows fra hele Indien og internationalt. Initiativet supplerer også Apollos voksende økosystem inden for robotkirurgi på tværs af specialer som gastrointestinal kirurgi, onkologi, urologi, ortopædi og hjertevidenskab. Ved at kombinere klinisk ekspertise med avanceret teknologi fortsætter Apollo Hospitals med at styrke sin rolle i at forme fremtiden for præcisionsdrevet, digitalt forbundet kirurgisk behandling. 

 Apollo Hospitals har indviet sin nyeste facilitet, Apollo Hospitals i Narendrapur, Vestbengalen, og markerer dermed en større udvidelse af sit sundhedsnetværk i staten. Med 250 senge kombinerer hospitalet topmoderne infrastruktur og avancerede medicinske tjenester for at levere omfattende pleje på tværs af en bred vifte af specialer. Faciliteten har syv operationsstuer, en intensivafdeling med 55 senge og en moderne knoglemarvstransplantationssuite (BMT), der gør det muligt for hospitalet at håndtere både rutinemæssige procedurer og komplekse medicinske interventioner. Patienterne drager også fordel af specialiserede afdelinger med fokus på specifikke sundhedsbehov, hvor erfarne klinikere yder personlig, evidensbaseret behandling. Hospitalet er strategisk placeret for forbedret tilgængelighed og tilbyder integrerede tjenester, der spænder over akut og kritisk pleje, medicinske og kirurgiske specialer samt rehabiliterende støtte. Avanceret diagnostik, intensiv pleje og koordinerede kliniske forløb muliggør rettidig og præcis behandling, samtidig med at patientsikkerhed og komfort prioriteres. Med lanceringen af ​​denne nye enhed styrker Apollo Hospitals det regionale sundhedsøkosystem yderligere og bringer klinisk ekspertise i verdensklasse tættere på lokalsamfundene i det sydlige Kolkata. Narendrapur-faciliteten afspejler Apollos løbende engagement i patientfokuseret, innovationsdrevet og resultatorienteret sundhedspleje. 

 Apollo Hospitals Ahmedabad har introduceret Pearl Wing, et gennemtænkt designet patientplejeområde, der er skabt for at forbedre helingsoplevelsen gennem komfort, ro og omsorgsfuld pleje. I erkendelse af, at heling rækker ud over medicinsk behandling, har Pearl Wing fornyet æstetik og patientcentrerede rum, der skaber et støttende og betryggende miljø for patienter og deres familier. Designet lægger vægt på komfort, privatliv og en beroligende atmosfære; elementer, der meningsfuldt kan understøtte patientens velbefindende under rekonvalescensen. Den nye fløj afspejler Apollo Hospitals' engagement i patientfokuseret sundhedspleje, hvor avanceret klinisk ekspertise suppleres af rum, der fremmer tryghed og værdighed. Ved at kombinere gennemtænkt design med omsorgsfuld pleje sigter Apollo Hospitals Ahmedabad mod at sikre, at patienter føler sig støttede gennem hele deres behandlings- og rekonvalescensproces. Pearl Wing repræsenterer et fornyet løfte fra Apollo Hospitals Ahmedabad om at levere pleje i et miljø, der fremmer komfort, selvtillid og heling. 

Indraprastha Apollo Hospitals, New Delhi, has achieved a major milestone in cardiac electrophysiology by successfully performing India’s first leadless pacemaker implantation through a metallic prosthetic tricuspid valve. The complex procedure was led by Dr Vanita Arora, Clinical Lead – Cardiac Electrophysiology, and her team, offering a safe and minimally invasive solution for patients with challenging cardiac conditions.  Dr Vanita Arora (centre) with the cardiac electrophysiology team after performing India’s first leadless pacemaker implantation through a metallic prosthetic tricuspid valve. The patient, a 65-year-old with a long history of cardiac illness, had previously undergone tricuspid valve replacement with a mechanical valve prosthesis. When he later developed symptomatic sinus node dysfunction and atrioventricular conduction disease, a permanent pacemaker was required to restore a stable heart rhythm. However, conventional pacemaker implantation was not feasible, as passing pacing leads through a mechanical tricuspid valve could damage the prosthesis and compromise valve function. To address this challenge, the team implanted a dual-chamber leadless pacemaker using a catheter-based approach through a vein in the leg. Unlike traditional pacemakers, leadless systems are compact, self-contained devices placed directly within the heart, eliminating the need for pacing leads and surgical pockets. This approach reduces the risk of infection, device-related complications, and interference with prosthetic valves. The procedure was carefully planned using advanced cardiac mapping and precise device positioning to restore heart rhythm while preserving the function of the prosthetic valve. The patient recovered well and was discharged in stable condition. This landmark intervention highlights the expanding role of leadless pacing technologies in managing complex cardiac rhythm disorders and reinforces Apollo Hospitals’ commitment to advancing innovation in cardiovascular care. 

Indraprastha Apollo Hospitals marked a proud moment as Dr Arun Prasad, Senior Consultant – Surgical Gastroenterology, was honoured at the UK House of Lords during the India–UK Achievers Honours 2026. Dr Prasad received the Science and Innovation Award at a parliamentary reception held at the UK Parliament, recognising his contributions to advancing minimal access gastrointestinal, bariatric, thoracic, and robotic surgery in India. The recognition celebrates individuals who have made significant contributions to science, innovation, and cross-border collaboration between India and the United Kingdom. The honour formed part of a three-day India–UK engagement programme, which also hosted the India–UK Education Conference. The event brought together over 700 leaders representing more than 350 universities, companies, and sector bodies, making it the largest international education convening in the UK focused on strengthening India–UK partnerships. With more than three decades of clinical experience, Dr Prasad has played a pioneering role in advancing minimally invasive and robotic surgical techniques, enabling greater precision, reduced surgical trauma, and faster recovery for patients. In addition to his clinical work, he has contributed extensively to surgical education and international knowledge exchange, strengthening global collaboration in modern surgical care.  Reflecting on the honour, Dr Prasad said, “To be announced as the winner in this category among global nominees is deeply humbling.” He also expressed his appreciation to the organisers, stating, “Grateful to Lord Karan Bilimoria, Commander of the Order of the British Empire (CBE) and Deputy Lieutenant (DL), Lord Uday Nagaraju, Member of the UK House of Lords, and the National Indian Students and Alumni Union (NISAU UK) for this distinguished recognition.” The recognition highlights the growing global impact of Indian clinicians and reinforces Apollo Hospitals’ commitment to fostering clinical excellence, innovation, and internationally recognised expertise in advanced surgical care. 

 Apollo Hospitals has expanded access to essential kidney care with the launch of the Apollo Dialysis Clinic at Waltax Road, strengthening renal services for communities in and around North Chennai. The centre has been established in partnership with the Chennai Metropolitan Development Authority (CMDA), Greater Chennai Corporation, and the Health Department, reflecting a collaborative effort to improve access to life-sustaining treatment. Chronic kidney disease continues to rise in India, often associated with conditions such as diabetes and hypertension. For patients requiring long-term dialysis, convenient and reliable access to treatment plays a crucial role in maintaining health and quality of life. The Waltax Road clinic is designed to provide dialysis consultation, treatment, and rehabilitation services in a patient-friendly environment, helping individuals receive regular care closer to home. By reducing travel burdens and improving treatment continuity, the centre supports better patient adherence and outcomes. This initiative highlights Apollo Hospitals’ continued commitment to strengthening community-based healthcare infrastructure and ensuring that advanced, compassionate renal care remains accessible to the patients who need it most. 

 Dr. Tripti Dubey has been honoured with the Excellence in Gynaecology & Obstetrics award at Femina GameChangers West 2026, recognising her outstanding contribution to advancing women’s healthcare through clinical expertise, innovation, and compassionate care. The prestigious Femina GameChangers platform celebrates individuals who create meaningful impact across industries, including healthcare, entrepreneurship, social initiatives, and leadership. This award acknowledges pioneers whose work drives positive change and sets new benchmarks of excellence in their fields. Dr. Dubey, Senior Consultant – Obstetrics, Gynaecology & Robotic Surgery at Apollo Hospitals Navi Mumbai, was celebrated for her dedication to evidence-based, patient-centric care for women across all stages of life. Her expertise spans preventive screenings, fertility care, high-risk obstetrics, and minimally invasive gynaecological procedures, reflecting a commitment to holistic women’s health. This recognition highlights Dr. Dubey’s role as a pioneer in gynaecology and obstetrics, demonstrating how clinical excellence, personalised care, and patient education can improve long-term health outcomes for women. This award underscores the importance of specialised, compassionate care and reinforces Dr. Dubey’s position as a leading voice in shaping the future of women’s healthcare in India.

Apollo Hospitals, Jubilee Hills, Hyderabad, has achieved a significant milestone by completing over 2,000 robotic-assisted surgeries, reinforcing its leadership in technology-driven, minimally invasive healthcare. The achievement reflects the hospital’s continued commitment to advancing surgical precision and improving patient outcomes through cutting-edge robotic platforms supported by multidisciplinary clinical expertise.  Robotic-assisted surgery represents an important advancement in modern surgical care. By integrating high-definition 3D visualisation, articulated robotic instruments, and surgeon-controlled precision, these procedures allow surgeons to perform complex operations with enhanced accuracy while minimising trauma to surrounding tissues. As a result, patients often benefit from smaller incisions, reduced blood loss, reduced postoperative pain, and faster recovery compared with traditional open surgery. At Apollo Hospitals Jubilee Hills, robotic surgery is used across multiple specialties, including urology, gastrointestinal surgery, cardiothoracic procedures, gynaecology, head and neck surgery, paediatric surgery, and general surgery, enabling clinicians to manage complex conditions using minimally invasive techniques. Commenting on the milestone, Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, highlighted that Apollo’s experienced surgical teams across specialties have successfully integrated robotic technology into routine practice. She noted that the minimally invasive platform enables surgeons to perform complex procedures with greater precision while helping patients experience reduced pain and faster recovery. This milestone underscores the growing role of robotic technology in shaping the future of surgery, reinforcing Apollo Hospitals’ ongoing focus on innovation-driven, patient-centred care that enhances surgical safety, recovery, and overall treatment outcomes. 

Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals Group, has been appointed President of NATHEALTH – Healthcare Federation of India for FY 2026-2027. She succeeds Ms. Ameera Shah, Executive Chairperson of Metropolis Healthcare, who previously served as the organisation's President. NATHEALTH shapes healthcare policy, strengthens public–private collaboration, and drives initiatives that improve accessibility, affordability, and quality of care across India. Dr. Reddy assumes this role at a pivotal time, as the healthcare sector focuses on expanding preventive care, accelerating digital health adoption, and building resilient healthcare systems for the future. A recognised healthcare leader and policy advocate, Dr. Reddy has played an instrumental role in advancing technology-enabled healthcare transformation. At Apollo Hospitals, she has helped drive initiatives in digital health, telemedicine, and data-driven healthcare platforms aimed at improving patient outcomes and expanding access to care. She has also been actively involved in national and global policy discussions on strengthening health systems and fostering innovation in healthcare delivery. As President of NATHEALTH, Dr. Reddy is expected to champion initiatives that support preventive healthcare, digital health integration, and sustainable healthcare delivery models aligned with India’s long-term vision for a healthier nation. Her leadership is expected to further strengthen collaboration between industry stakeholders and policymakers, advancing a patient-centric, innovation-driven healthcare ecosystem for India’s future. 

Et tværfagligt team på Apollo Hospitals, Navi Mumbai, har med succes udført en robotbaseret hysterektomi på en 37-årig kvinde diagnosticeret med Glanzmanns trombasteni, en sjælden genetisk tilstand, der alvorligt forringer blodets evne til at størkne og kan føre til livstruende blødninger. Fra venstre mod højre: Dr. Punit Jain - seniorkonsulent i hæmatologi, hæmato-onkologi og programkoordinator for knoglemarvstransplantation og CAR T-celleterapi, Apollo Hospitals, Navi Mumbai, fru Neelam Yadav (patient), Dr. Tripti Dubey - seniorkonsulent i obstetrik, gynækologi og robotkirurgi, Apollo Hospitals, Navi Mumbai, og hr. Sudhir Yadav (patientens mand). Patienten havde i årevis udholdt alvorlig menstruationsblødning, der ofte krævede hospitalsindlæggelse og blodtransfusioner. Under en nylig episode faldt hendes hæmoglobinniveau til kritisk lave 4 g/dl, hvilket fik lægerne til at anbefale en hysterektomi som en definitiv løsning for at forhindre tilbagevendende blødninger og forbedre hendes livskvalitet på lang sigt. Lægerne bemærkede også, at kvinden tidligere havde født et barn via kejsersnit og havde brug for flere blod- og blodpladetransfusioner på det tidspunkt på grund af komplikationer relateret til hendes underliggende blødningsforstyrrelse. Kirurgi hos patienter med Glanzmanns trombasteni er særligt kompleks på grund af risikoen for ukontrolleret blødning, selv fra mindre kirurgiske indgreb. For at afbøde disse risici valgte det kliniske team en robotassisteret minimalt invasiv procedure. Operationen blev ledet af Dr. Tripti Dubey (Seniorkonsulent – ​​Obstetrik, Gynækologi og Robotkirurgi, Apollo Hospitals) i samarbejde med Dr. Punit Jain (Konsulent – ​​Hæmatologi, Hæmato-Onkologi og Knoglemarvstransplantationsspecialist, Apollo Hospitals), der kombinerede ekspertise inden for robotgynækologi og hæmatologi for omhyggeligt at håndtere patientens koagulationsforstyrrelse. Operationen blev gennemført med næsten nul intraoperativt blodtab og uden behov for transfusion under proceduren – en bemærkelsesværdig præstation i betragtning af patientens underliggende tilstand. Efter en overvåget postoperativ bedring stabiliserede patienten sig godt og var i stand til at genoptage rutinemæssige aktiviteter kort efter. Denne sag understreger den voksende rolle, som robotkirurgi spiller i håndteringen af ​​komplekse tilstande med høj risiko. Ved at muliggøre forbedret præcision, mindre snit og forbedret kontrol under delikate procedurer hjælper robotplatforme klinikere med at udvide grænserne for sikker kirurgisk behandling af patienter med sjældne og udfordrende lidelser. 

I en skelsættende procedure på Verdens Høredag ​​(3. marts 2026) udførte Apollo Children's Hospitals i Chennai med succes Tamil Nadus første Cochlear™ Nucleus® Nexa™-implantatoperation på en niårig pige fra Bangladesh. Hun er født med svært til svært høretab og vil nu begynde et struktureret postoperativt program for at optimere tale- og sprogudviklingen. Ledet af Dr. Venkatakarthikeyan C, ledende overlæge, ØNH og hoved- og halsrobotkirurg, anvendte teamet Cochlear Nucleus Nexa - verdens første smarte cochlear-implantat drevet af NEXOS™-chipsættet - hvilket placerer Apollo Children's Hospitals blandt de tidlige centre i Indien, der tilbyder denne næste generations teknologi. Dette system understøtter firmwareopgraderinger, hvilket muliggør fremtidige forbedringer uden yderligere kirurgi. Dets avancerede signalbehandlings- og stimuleringsteknologier forbedrer lydklarheden i udfordrende lyttemiljøer og understøtter bedre talegenkendelse og kommunikation. I de kommende uger vil barnet gå ind i den næste fase af behandlingen, hvor den eksterne lydprocessor vil blive aktiveret og programmeret til at optimere høreresultaterne. Hun er i bedring og forbliver under omhyggelig klinisk observation som en del af den postoperative plejeprotokol. Dr. Venkatakarthikeyan understregede: "Konsekvent adgang til lyd gennem denne fremtidssikrede teknologi kan i betydelig grad hjælpe et barns tale, sprog og kognitive udvikling, samtidig med at det fremmer socialt engagement." Dr. Ilankumaran Kaliamoorthy, administrerende direktør for Chennai-regionen, Apollo Hospitals, tilføjede: "Denne præstation afspejler vores engagement i at levere banebrydende høreløsninger til børn i hele Indien og nabolandene. Vi fortsætter med at investere i avanceret teknologi og tværfaglig pleje for at sikre de bedste langsigtede resultater." Introduktionen af ​​denne teknologi udvider behandlingsmulighederne for pædiatrisk høretab i Tamil Nadu og de omkringliggende regioner og giver fornyet håb om forbedret kommunikation, akademiske fremskridt og generel livskvalitet.